$1.38
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Surprise, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Country

US

CEO

Mr. Joel Fruendt

IPO date

2016

Employees

23

ISIN

US81720R6045

Key stats

Open

$1.44

Volume

73.88K

Market cap

$7.32M

Prev. close

$1.38

Impl / hst vl

-

Open interest

$0.00

$1.37

Day’s Range

$1.44

$1.38

52W Range

$2.53

Valuation

61
Valuation score
Undervalued
P/E
-
P/S
3.28
P/B
0.95
Current ratio
8.91
Debt / Equity
-0.86
ROE
-76.20%
Gross margin
68.56%
Income growth
14.36%
FCF growth
15.03

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$6.89
The top 4 analysts forecasts that 12-month price may increase by 398.91%, with a low of $3.54 and a high of $10.50
$3.54
Low
$6.89
Avg
$10.50
High
Current price

Earnings

Q1 ‘26 revenue
$493.00K
Q1 ‘26 net income
-$2.06M
Revenue
Net income
Previous EPS
-$0.31
Estimate EPS
-$0.37
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply